Astellas Pharma Inc.
Need
Astellas Pharma Inc. wanted an innovative way to strengthen its relationship with a specific audience—the community of liver and kidney transplant patients which uses its anti-rejection drug, ProGraf.
Solution
NCI Mobility is providing interactive, wireless applications to gather information from this key market at health and lifestyle-focused experiences sponsored by Astellas as part of high-profile medical conferences and events. Brand ambassadors use table-top kiosks, tablet and ultra mobile PCs to collect answers to specific questions and basic information from existing and prospective patients at each event.
Results
At the National Kidney Foundation U.S. Transplant Games 2006, Astellas’ hosted over 1000 transplant recipients and athletes. The information gathered from this and other events is helping Astellas shape its future and keep in touch with its existing customer base. At the same time, patients, their families, and caregivers benefit by receiving regular news and information about healthy transplant lifestyles and important changes to Astellas’ products.
